These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31769119)

  • 1. Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation.
    Tsai KL; Vernau KM; Winger K; Zwueste DM; Sturges BK; Knipe M; Williams DC; Anderson KJ; Evans JM; Guo LT; Clark LA; Shelton GD
    J Vet Intern Med; 2020 Jan; 34(1):258-265. PubMed ID: 31769119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome.
    Rinz CJ; Levine J; Minor KM; Humphries HD; Lara R; Starr-Moss AN; Guo LT; Williams DC; Shelton GD; Clark LA
    PLoS One; 2014; 9(8):e106425. PubMed ID: 25166616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis and congenital myasthenic syndromes in dogs and cats: A history and mini-review.
    Shelton GD
    Neuromuscul Disord; 2016 Jun; 26(6):331-4. PubMed ID: 27080328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome.
    Abitbol M; Hitte C; Bossé P; Blanchard-Gutton N; Thomas A; Martignat L; Blot S; Tiret L
    PLoS One; 2015; 10(9):e0137019. PubMed ID: 26327126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ.
    Barbeau S; Semprez F; Dobbertin A; Merriadec L; Roussange F; Eymard B; Sternberg D; Fournier E; Karasoy H; Martinat C; Legay C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
    Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families.
    Kediha MI; Tazir M; Magnouche C; Sternberg D; Belarbi S; Eymard B; Ali Pacha L
    Rev Neurol (Paris); 2023 Jun; 179(6):570-575. PubMed ID: 36764859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.
    Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK
    J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COLQ-related congenital myasthenic syndrome: An integrative view.
    Eshaghian T; Rabbani B; Badv RS; Mikaeeli S; Gharib B; Iyadurai S; Mahdieh N
    Neurogenetics; 2023 Jul; 24(3):189-200. PubMed ID: 37231228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COLQ variant associated with Devon Rex and Sphynx feline hereditary myopathy.
    Gandolfi B; Grahn RA; Creighton EK; Williams DC; Dickinson PJ; Sturges BK; Guo LT; Shelton GD; Leegwater PA; Longeri M; Malik R; Lyons LA
    Anim Genet; 2015 Dec; 46(6):711-5. PubMed ID: 26374066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature.
    El Kadiri Y; Ratbi I; Sefiani A; Lyahyai J
    BMC Neurol; 2022 Aug; 22(1):292. PubMed ID: 35932018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.
    Hesami O; Ramezani M; Ghasemi A; Fatehi F; Okhovat AA; Ziaadini B; Kariminejad A; Nafissi S
    Orphanet J Rare Dis; 2024 Mar; 19(1):113. PubMed ID: 38475910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.
    Legay C
    Ann N Y Acad Sci; 2018 Feb; 1413(1):104-110. PubMed ID: 29405353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First characterization of congenital myasthenic syndrome type 5 in North Africa.
    Khaoula R; Cerino M; Da Silva N; Delague V; Nahili H; Kriouile Y; Gorokhova S; Bartoli M; Saïle R; Barakat A; Krahn M
    Mol Biol Rep; 2021 Oct; 48(10):6999-7006. PubMed ID: 34553317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.